PT3111942T - Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco - Google Patents

Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Info

Publication number
PT3111942T
PT3111942T PT161756523T PT16175652T PT3111942T PT 3111942 T PT3111942 T PT 3111942T PT 161756523 T PT161756523 T PT 161756523T PT 16175652 T PT16175652 T PT 16175652T PT 3111942 T PT3111942 T PT 3111942T
Authority
PT
Portugal
Prior art keywords
infants
prevention
risk
compositions
treatment
Prior art date
Application number
PT161756523T
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49582658&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3111942(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PT3111942T publication Critical patent/PT3111942T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
PT161756523T 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco PT3111942T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13193087 2013-11-15

Publications (1)

Publication Number Publication Date
PT3111942T true PT3111942T (pt) 2021-03-23

Family

ID=49582658

Family Applications (2)

Application Number Title Priority Date Filing Date
PT147988547T PT3068404T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
PT161756523T PT3111942T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT147988547T PT3068404T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Country Status (10)

Country Link
US (2) US10357506B2 (pt)
EP (2) EP3068404B1 (pt)
CN (2) CN114468302A (pt)
AU (1) AU2014350144B2 (pt)
ES (2) ES2856013T3 (pt)
MX (1) MX2016005961A (pt)
PH (1) PH12016500764A1 (pt)
PT (2) PT3068404T (pt)
RU (1) RU2707570C1 (pt)
WO (1) WO2015071389A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758555B2 (en) * 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
EP3068404B1 (en) 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
WO2016066735A1 (en) * 2014-10-31 2016-05-06 Nestec S.A. Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
WO2016139330A1 (en) * 2015-03-05 2016-09-09 Nestec S.A. Compositions for use in improving stool consistency or frequency in infants or young children
EP3298404B1 (en) 2015-05-19 2022-04-20 Société des Produits Nestlé S.A. Kit-of-parts to identify mother's milk missing fucosyltransferase-2 dependent glycans
MX2018007124A (es) 2015-12-15 2018-09-07 Nestec Sa Mezcla de hmo.
US20190160082A1 (en) * 2016-08-04 2019-05-30 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
CN110573164B (zh) * 2017-03-08 2023-09-29 N·V·努特里奇亚 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物
MX2019013252A (es) * 2017-05-24 2020-01-15 Société des Produits Nestlé SA Mezclas de hmo para usar en infantes o niños pequeños con fines de salud.
EP3648618A1 (en) * 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
AU2018295414A1 (en) * 2017-07-07 2020-01-16 Societe Des Produits Nestle S.A. Human milk fortifier
TW201924696A (zh) * 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 母體補充劑
US11701404B2 (en) * 2017-12-01 2023-07-18 Societe Des Produits Nestle S.A. Human milk fortifier composition
EP3494806A1 (en) * 2017-12-08 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried lacto-n-fucopentaose
EP3494805A1 (en) * 2017-12-08 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried tetrasaccharides
EP3494807A1 (en) * 2017-12-11 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried sialyllactose
EP3494804A1 (en) * 2017-12-08 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried 3-fucosyllactose
AT17129U1 (de) * 2017-12-08 2021-06-15 Jennewein Biotechnologie Gmbh Sprühgetrocknetes Gemisch humaner Milch-Oligosaccharide
US20220054514A1 (en) * 2018-12-20 2022-02-24 Société des Produits Nestlé S.A. Human milk fortifier composition
WO2021195011A1 (en) * 2020-03-24 2021-09-30 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the treatment of viral respiratory infection
CA3178736A1 (en) * 2020-05-13 2021-11-18 Ardythe L. Morrow 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
WO2021231751A1 (en) * 2020-05-13 2021-11-18 Glycosyn LLC Fucosylated oligosaccharides for prevention of coronavirus infection
CN112841316B (zh) * 2021-02-03 2021-11-05 合生元(广州)健康产品有限公司 包含低聚糖的个性化营养组合物
CN116981463A (zh) * 2021-03-22 2023-10-31 雀巢产品有限公司 人乳低聚糖
WO2022221349A2 (en) * 2021-04-15 2022-10-20 Intrinsic Medicine, Inc. Methods and compositions for treating long covid-19

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6045854A (en) 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
WO2001077313A1 (fr) 2000-04-11 2001-10-18 Kyowa Hakko Kogyo Co., Ltd. α1,2-FUCOSYLTRANSFERASE ET PROCEDE SERVANT A PREPARER UN GLUCIDE COMPLEXE CONTENANT FUCOSE
US7893041B2 (en) 2003-12-05 2011-02-22 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ATE361101T1 (de) 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
EP1988786B2 (en) * 2006-02-10 2019-10-09 Société des Produits Nestlé S.A. Oligosaccharide mixture
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
DK2839836T3 (en) 2006-10-02 2017-12-04 Dupont Nutrition Biosci Aps Probiotics for use in reducing symptoms of respiratory disease
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CN101939411A (zh) * 2008-02-06 2011-01-05 宝洁公司 用于提高呼吸病症免疫应答的组合物、方法和试剂盒
PT2265135T (pt) * 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US20110097437A1 (en) 2008-06-13 2011-04-28 N.V. Nutricia Nutrition for prevention of infections
WO2010002241A1 (en) 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
JP2010035738A (ja) * 2008-08-04 2010-02-18 Toyota Boshoku Corp 車両用シートの連結装置
RU2530641C2 (ru) * 2009-07-15 2014-10-10 Н.В. Нютрисиа Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой
EP2662084A1 (en) 2009-07-15 2013-11-13 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
US20120315250A1 (en) * 2009-12-28 2012-12-13 Suomen Punainen Risti Veripalvelu Probiotic bifidobacterial composition in accordance with secretor blood group status
FI20096402A0 (fi) 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö II
WO2011136648A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of human milk oligosaccharides in infant nutrition
US9243753B2 (en) * 2010-08-04 2016-01-26 Scott Fredric Wonders Compressed gas flow initiated and controlled automatic sequencing cascade system for the recharging of compressed gas cylinders
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
TWI528899B (zh) * 2010-12-29 2016-04-11 杜邦股份有限公司 中離子性殺蟲劑
EP2658546B1 (en) * 2010-12-31 2018-12-05 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
CN103379908B (zh) * 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
EP3068404B1 (en) * 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk

Also Published As

Publication number Publication date
CN114468302A (zh) 2022-05-13
AU2014350144A1 (en) 2016-04-07
ES2856013T3 (es) 2021-09-27
EP3068404A1 (en) 2016-09-21
PH12016500764B1 (en) 2016-05-30
US20160287618A1 (en) 2016-10-06
WO2015071389A1 (en) 2015-05-21
CN105722515A (zh) 2016-06-29
US20190290668A1 (en) 2019-09-26
US11419885B2 (en) 2022-08-23
US10357506B2 (en) 2019-07-23
RU2016123516A (ru) 2017-12-20
AU2014350144B2 (en) 2019-11-21
PT3068404T (pt) 2021-03-22
EP3111942A1 (en) 2017-01-04
PH12016500764A1 (en) 2016-05-30
ES2857077T3 (es) 2021-09-28
EP3111942B1 (en) 2021-01-06
EP3068404B1 (en) 2021-01-06
RU2707570C1 (ru) 2019-11-28
MX2016005961A (es) 2016-12-16

Similar Documents

Publication Publication Date Title
PT3111942T (pt) Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
ZA201604034B (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PT3264923T (pt) Composições para utilização na prevenção ou tratamento de infeções gastrointestinais em lactentes ou crianças pequenas
HK1252786A1 (zh) 包含5-苯氧基-3h-嘧啶-4-酮衍生物的組合物及其用於預防或治療hiv感染的方法
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
PH12016500868A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
ZA201703637B (en) Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children
EP2948436A4 (en) NOVEL CASES IN THE TREATMENT OF MACULAR GENERATION
EP2986316A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND / OR PROPHYLAXIS OF A DIFFICULT CLOSTRIDIUM ASSOCIATED DISEASE
HUE046924T2 (hu) Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
PL2961822T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
HK1225994A1 (zh) 用於治療過敏性病症的組合物
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
ZA201703638B (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
GB201421860D0 (en) Children's play kitchen
EP2968127A4 (en) LOW GLYCEROL PREPARATIONS FOR HIV TREATMENT AND PREVENTION
TH1601002624A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือรักษาการติดเชื้อ urt ในทารกหรือเด็ก เล็กที่มีความเสี่ยง
TH1601002626A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือการรักษาโรคลำไส้อักเสบชนิดเนื้อตาย ในทารกและเด็กเล็ก
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry
AU2013901658A0 (en) Compositions and methods for the treatment of tinnitus